Cooper Lighting, has announced that three of its LED architectural products have been recognized for ingenuity in Architectural Products Product Innovation Awards (PIA) competition. For the second consecutive year, Cooper Lighting has the ...
Tags: cooper lighting, Norh America LED lighting, LED architectural products
PPG Industries' Charles Bunch, chairman and CEO, along with Charles Kahle the company's chief technology officer, recognized four science and technology leaders into the PPG Collegium. The individuals were selected based on their ...
Tags: automotive coatings, decorative coatings, automotive finishing
USA - LumenRadio has confirmed 0energyLighting Inc as its newest OEM partner. The US based company is a renowned manufacturer of the FlexAray Stage and Studio LED luminaries with its patent pending hexagonal shape. This design allows ...
Tags: partner, studio LED luminaries, patent, hexagonal shape, fixtures, LEDs
Intervening in a patent dispute between Apple and Motorola Mobility,the U.S.Federal Trade Commission has opposed bans on the sale of products that include standardized,patented technology when the patent holder has previously committed to ...
Tags: patent dispute, Motorola, U.S.Federal Trade Commission, Apple
A patent agreement between Apple and HTC forbids the Taiwanese company from making and selling mobile devices that copy what is described as the'Distinctive Apple User Experience,"according to a redacted version of the agreement filed in a ...
Tags: Apple, HTC, Distinctive Apple User Experience, design patents
Urban Barns Foods Canada has announced a collaborative research with McGill University over Cubic Agriculture growing practices. Urban Barns' Cubic Agriculture employs patent pending proprietary equipment to grow affordable vegetables in ...
Jazz Pharmaceuticals has received a US patent for the use of Xyrem (sodium oxybate) oral solution in narcolepsy treatment. The new patent entitled Microbiologically Sound and Stable Solutions of Gamma-Hydroxybutyrate Salt for the ...
Tags: pharmaceuticals, US patent, sodium oxybate, narcolepsy
Teva Pharmaceutical Industries has entered into a settlement agreement related to Nuvigil patent infringement litigation with Mylan. Under the agreement, Mylan is allowed to sell generic versions of 50mg, 150mg, and 250mg Nuvigil in June ...
Tags: Nuvigil, armodafinil tablets, Teva Pharmaceutical Industries, Mylan
TherapeuticsMD, a parent company of vitaMedMD, has filed additional patent applications for its prescription products to treat menopausal symptoms and related conditions. The patent applications concern its proprietary formulation ...
Tags: TX12001HR, TX12002HR, TX12003HR, TherapeuticsMD
The US Patent and Trademark Office (USPTO) has granted a patent for the use of Aeterna Zentaris' oral ghrelin agonist, AEZS-130 (EP1572) as a diagnostic test for adult growth hormone deficiency (AGHD). AEZS-130, which has been granted ...
Tags: AEZS-130, growth hormone deficiency, AGHD
Inhaled nitric oxide drug products developer GeNO has received four additional US patents on its proprietary inhaled nitric oxide (NO) generation chemistry and delivery technology, bringing the total number of US patents to sixteen. The ...
Tags: inhaled nitric oxide drug, NO, NO2, GeNO
RegeneRx Biopharmaceuticals has received an issued patent in Mexico and allowances of three additional patent applications in Mexico and Israel, related to Thymosin beta 4 (Tβ4). The patents are set to expire 2024-2026, the ...
StemCells has obtained US Patent for its human liver engrafting cells (hLEC), under patent number 8,283,164 titled 'Liver engrafting cells, assays and uses thereof'. Researchers of the firm have demonstrated the hLEC cells engraftment and ...
Mylan Pharmaceuticals has gained final FDA approval for its abbreviated new drug application (ANDA) for Fluvastatin Capsules USP, 20mg and 40mg, and began shipment of the product. The product, a generic version of Novartis' Lescol ...
MicuRx Pharmaceuticals has received a US patent from the USPTO covering the composition of its clinical candidate, MRX-I. The antibacterial oxazolidinone targets infections due to multi-drug resistant Gram-positive pathogens. MicuRx ...
Tags: MicuRx Pharmaceuticals, MRX-I